Trump Nominee, Tom Price, Faces Multiple Allegations of Insider Trading

by Zack Ford – Rep. Tom Price (R-GA) bought stock, then introduced legislation that boosted its value. This week, the Senate will hold confirmation hearings for Rep. Tom Price (R-GA), President-elect Donald Trump’s pick for Secretary of Health and Human Services. Monday evening, CNN reported that Price may have used his position in Congress for profit in what appears to be insider trading, a new allegation among many that are now clouding his nomination. Last March, Price bought as much as $15,000 in stock in a company called Zimmer Biomet, one the world’s largest manufacturers of knee and hip implants. Within a week of that transaction, he introduced the HIP Act, a bill that would have saved Zimmer Biomet a significant amount of money by delaying implementation of a Centers for Medicare and Medicaid (CMS) payment model for hip and knee replacements. After Price introduced the bill, Zimmer Biomet’s political action committee...

Read More...